Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients (CMD-IBS09(2))
|ClinicalTrials.gov Identifier: NCT01370720|
Recruitment Status : Unknown
Verified June 2012 by MARIA CRISTINA COMELLI, CM&D Pharma Limited.
Recruitment status was: Recruiting
First Posted : June 10, 2011
Last Update Posted : June 19, 2012
MARIA CRISTINA COMELLI
Information provided by (Responsible Party):
MARIA CRISTINA COMELLI, CM&D Pharma Limited
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||January 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Cremon C, Stanghellini V, Barbaro MR, Cogliandro RF, Bellacosa L, Santos J, Vicario M, Pigrau M, Alonso Cotoner C, Lobo B, Azpiroz F, Bruley des Varannes S, Neunlist M, DeFilippis D, Iuvone T, Petrosino S, Di Marzo V, Barbara G. Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome. Aliment Pharmacol Ther. 2017 Apr;45(7):909-922. doi: 10.1111/apt.13958. Epub 2017 Feb 6.